Neurocutaneous syndromes: behavioral features (Q36183528)

12 August 2017

1 reference

title

Neurocutaneous syndromes: behavioral features (English)

1 reference

12 August 2017

Charles M Zaroff

1

1 reference

12 August 2017

Keren Isaacs

series ordinal

2

1 reference

12 August 2017

publication date

1 September 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

133-142

1 reference

Pathophysiology of Sturge-Weber syndrome

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Sturge-Weber syndrome: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Outcome of Sturge‐Weber syndrome in 52 adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Sturge-Weber syndrome: study of 40 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Quantitative analysis of gray- and white-matter volumes and glucose metabolism in Sturge-Weber syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Sturge-Weber syndrome revisited: the role of neuroradiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Regional cerebral blood flow characteristics of the Sturge-Weber syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Prognosis in Sturge-Weber disease: comparison of unihemispheric and bihemispheric involvement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Psychological functioning in children and adolescents with Sturge-Weber syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Outcome of infants with unilateral Sturge-Weber syndrome and early onset seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

A study on Sturge-Weber syndrome. Report of a case associated with infantile spasms and electroencephalographic evolution in five cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Sturge-Weber syndrome: correlation between clinical course and FDG PET findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Treatment of encephalotrigeminal angiomatosis (Sturge-Weber disease) by hemispherectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Psychopathology in Sturge-Weber syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Epidemiology of tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

National Institutes of Health consensus conference: tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Genotype-phenotype correlations in tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

A prospective longitudinal study of early cognitive development in tuberous sclerosis - a clinic based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Genotype and psychological phenotype in tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Poor mental development in patients with tuberous sclerosis complex: clinical risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neuropsychiatric aspects of tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Epilepsy surgery for tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Surgical treatment for epilepsy in cerebral tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Pediatric temporal lobectomy for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Transmantle dysplasia in tuberous sclerosis: clinical features and surgical outcome in four children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Long-term outcome of epilepsy surgery in patients with tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Molecular Genetic and Phenotypic Analysis Reveals Differences between TSC1 and TSC2 Associated Familial and Sporadic Tuberous Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Aetiology of autism: findings and questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Association of tuberous sclerosis of temporal lobes with autism and atypical autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

A prevalence study of autism in tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Autism in tuberous sclerosis: evoked potential evidence for a deficit in auditory sensory processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Supratentorial tuber location and autism in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Autism and tuberous sclerosis complex: prevalence and clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Autism and the cerebellum: evidence from tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Autism in tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Monozygotic twins with tuberous sclerosis discordant for the severity of developmental deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Behavioral phenotypes in four mental retardation syndromes: fetal alcohol syndrome, Prader-Willi syndrome, fragile X syndrome, and tuberosis sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Clinical aspects of neurofibromatosis 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

The management of brainstem gliomas in patients with neurofibromatosis 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neuropsychological profile of children with neurofibromatosis, brain tumor, or both.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Behavioral phenotype of neurofibromatosis, type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Language and reading deficits associated with Neurofibromatosis Type 1: Evidence for a not‐so‐nonverbal learning disability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: nonverbal learning disabilities revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Learning Disability Subtypes in Children with Neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Visual-spatial performance deficits in children with neurofibromatosis type-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

COGNITIVE FUNCTION AND ACADEMIC PERFORMANCE IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Type 1 neurofibromatosis and the pediatric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Intellectual impairment in neurofibromatosis 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neurofibromatosis type 1: the cognitive phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Evolution of white matter lesions in neurofibromatosis type 1: MR findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Neurofibromatosis type 1: magnetic resonance imaging findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

A neurofibromatosis-1-regulated pathway is required for learning in Drosophila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Social skills of children with neurofibromatosis type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Treatment of ADHD in neurofibromatosis type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

Psychiatric disorder among children with tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.05.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2005.05.012

1 reference

12 August 2017

1 reference